Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group

2022100 citationsJournal Articlehybrid Open Access

Authors

Riad Salem · Northwestern University

Siddharth A. Padia · University of California, Los Angeles

Marnix Lam · University Medical Center Utrecht

Claudio Chiesa · Istituti di Ricovero e Cura a Carattere Scientifico

Paul Haste · University School

Bruno Sangro · Centro de Investigación Biomédica en Red

Beau Toskich

Abstract

Updated consensus recommendations are provided to guide clinical and dosimetric approaches for the use of Y-90 glass microsphere TARE in HCC, accounting for disease presentation, tumor biology, and treatment intent.

Topics & Keywords

Hepatocellular Carcinoma Treatment and Prognosis Radiopharmaceutical Chemistry and Applications Medical Imaging and Pathology Studies

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: European Journal of Nuclear Medicine and Molecular Imaging

Volume 50, Issue 2, pp. 328-343

DOI: 10.1007/s00259-022-05956-w

Field-Weighted Citation Impact: 13.02